Therapy Development Director, Coronary Therapies EMEA at Boston Scientific Corporation Malaysia

Hemel Hempstead, England, United Kingdom -

Full Time

Start Date

Immediate

Expiry Date

16 Jan, 26

Salary

0.0

Posted On

18 Oct, 25

Experience

10 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

Skills

Commercial Strategy, Sales Leadership, Market Development, Interventional Cardiology, Therapy Adoption, Strategic Thinking, Analytical Skills, Problem-Solving, Communication Skills, Influencing Skills, Cross-Functional Leadership, Training Program Development, Customer Feedback Analysis, Competitive Intelligence, Key Opinion Leader Engagement, Collaboration

Industry

Medical Equipment Manufacturing

Description

Commercial Strategy & Execution Define and execute regional commercial strategies to accelerate growth and market leadership in Modern PCI. Own commercial outcomes with accountability for top-line revenue, therapy adoption, and category share gains. Partner closely with local and regional leadership team, cluster directors and business unit managers on planning, performance reviews during QBRs, and field support activities. Design and implement regional strategies that reflect market dynamics, leveraging field insights, competitive intelligence, and customer feedback. Drive go-to-market evolution and sales organization transformation, expansion into new therapies and in strong collaboration with local commercial leaders and the commercial excellence team. Accelerate therapy adoption and optimize revenue performance across the Coronary Therapies portfolio. Accountable for top-line sales in Modern PCI. Act as a key voice from EMEA into global franchise strategy forums. Build and maintain strategic relationships with Key Opinion Leaders (KOLs) and clinical influencers. Oversee development of training programs in collaboration with the Commercial Excellence, Marketing and Medical Education Team tailored to Modern PCI therapies and our new technologies. Drive comprehensive training programs to build Modern PCI competencies across EMEA sales teams and overall development of field based team aligning with Therapy needs including future portfolio expansions (Renal Denervation & Interventional Heart Failure). Proven sales leadership experience with extensive exposure to interventional cardiology or related cardiovascular therapies. Demonstrated success in strategic sales, market development, or business unit leadership roles. Track record of cross-border leadership, new technology launches, and therapy adoption acceleration. Strong strategic thinker with analytical, problem-solving, and execution capabilities. Exceptional communicator with proven ability to influence senior stakeholders, physicians, and commercial teams. Proven ability to lead collaboratively and influence effectively within complex matrix structures and cross-functional teams. Fluent in English; additional proficiency in French, German, Italian, or Spanish is highly desirable. Willingness and ability to travel extensively across EMEA. Direct experience with PCI and emerging cardiovascular therapies (e.g., Interventional HF, Renal Denervation). Bachelor's degree required; Master's degree (MSc) in a technical, clinical, or business-related discipline is preferred.

Responsibilities

Define and execute regional commercial strategies to accelerate growth and market leadership in Modern PCI. Build and maintain strategic relationships with Key Opinion Leaders and oversee the development of training programs tailored to Modern PCI therapies.